Embecta Corp. (EMBC) stock

EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3079% below fair value

$6.43−0.10 (-1.53%)

Close on Nov 12, 2026Market cap $364.32MP/E 4.4Yield 9.33%

Embecta statistics

102 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Nov 24, 2026 (estimated, before the open)
Last ex-dividend date: Aug 27, 2026
Fundamentals through: Jun 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $364.32M; $501.02M
Enterprise Value: $1.60B; $422.54M
PE Ratio: 4.37; 29.97
PS Ratio: 0.36; 3.04
P/FCF Ratio: 2.21; 26.37
P/OCF Ratio: 2.09; 22.12

Enterprise valuationIndustry

EV / Sales: 1.58; 2.70
EV / EBITDA: 5.99; 18.53
EV / EBIT: 7.18; 24.04
EV / FCF: 9.75; 27.78

Share statisticsIndustry

Shares Outstanding: 57M; 43M
Shares Change (YoY): 0.88%; 3.22%
Shares Change (QoQ): -4.50%; 0.16%
Float: 54M; 37M
Shares Held by Insiders: 3.87%; 10.5%
Shares Held by Institutions: 88.9%; 60.2%

Short sellingIndustry

Short Interest: 6M; –
Short Interest Change: -0.93%; -2.57%
Short % of Float: 10.7%; 5.12%
Short % of Shares Outstanding: 10.3%; 3.98%
Days to Cover: 6.83; 3.94

Stock price statisticsIndustry

52-Week High: $14.91; –
52-Week Low: $2.77; –
20-Day Moving Average: $6.44; –
50-Day Moving Average: $5.95; –
200-Day Moving Average: $6.20; –
Average True Range (14): $0.32; –
Price Change (1 Week): 1.58%; 2.01%
Price Change (1 Month): 4.05%; -0.57%
Price Change (3 Months): 26.1%; -7.91%
Price Change (6 Months): 104.8%; -0.90%
Price Change (YTD): -45.9%; -0.82%
Price Change (1 Year): -54.8%; -1.18%
Price Change (3 Years): -56.6%; 6.56%
Average Volume (10 Days): 772,058; –
Average Volume (20 Days): 819,271; –
Average Volume (90 Days): 1M; –
Relative Volume: 0.80; 0.82
Relative Strength Index (14): 54.3; 47.7
Volatility (1 Year): 81.8%; 64.2%
Beta (5 Years): 0.68; 1.05

MarginsIndustry

Gross Margin: 59.0%; 55.9%
Operating Margin: 21.9%; -5.17%
Pretax Margin: 12.3%; -2.55%
Profit Margin: 8.59%; -9.23%
EBITDA Margin: 26.3%; -2.82%
FCF Margin: 16.2%; 0.40%

Returns on capitalIndustry

Return on Assets (ROA): 7.22%; -12.2%
Return on Invested Capital (ROIC): 26.2%; -3.22%
Return on Capital Employed (ROCE): 26.4%; -8.13%

Financial positionIndustry

Current Ratio: 1.68; 2.45
Quick Ratio: 0.95; 1.53
Debt / EBITDA: 5.44; 2.19
Debt / FCF: 8.84; 3.62
Net Debt / EBITDA: 4.63; 1.53

GrowthIndustry

Revenue Growth (YoY): -7.60%; 9.24%
Net Income Growth (YoY): 4.67%; 13.4%
EPS Growth (YoY): 2.80%; 15.1%
FCF Growth (YoY): 24.4%; 7.64%
Revenue Growth (3Y CAGR): -1.47%; 7.08%
Revenue Growth (5Y CAGR): -0.09%; 11.8%
EPS Growth (3Y CAGR): -25.3%; 3.11%
EPS Growth (5Y CAGR): -26.4%; 7.64%

EfficiencyIndustry

Asset Turnover: 0.84; 0.59
Inventory Turnover: 2.07; 2.20
Revenue Per Employee: $550.65K; $330.60K
Profits Per Employee: $47.30K; -$41.39K
Employee Count: 1,850; 186
WACC: 5.51%; 9.71%

Income statement (TTM)Industry

Revenue: $1.02B; $106.81M
Gross Profit: $601.30M; $62.29M
Operating Income: $223.50M; -$4.10M
Pretax Income: $125.00M; -$1.69M
Net Income: $87.50M; -$6.19M
EBITDA: $267.70M; -$1.98M
EPS (Diluted): $1.47; -$0.08

Balance sheetIndustry

Cash & Short-Term Investments: $214.70M; $38.08M
Total Debt: $1.46B; $96.00M
Net Cash (Debt): -$1.24B; $3.73M
Net Cash Per Share: -$21.89; $0.24
Equity (Book Value): -$612.70M; $63.44M
Book Value Per Share: -$10.81; $3.26
Tangible Book Value: -$700.10M; $11.04M
Working Capital: $285.30M; $56.85M

Cash flow (TTM)Industry

Operating Cash Flow: $174.10M; -$541.49K
Capital Expenditures: -$9.50M; -$3.69M
Free Cash Flow: $164.60M; -$387.37K
FCF Per Share: $2.91; -$0.01

Dividends and yieldsIndustry

Earnings Yield: 24.0%; -4.70%
FCF Yield: 45.2%; 0.24%
Dividend Yield: 9.33%; 0.80%
Shareholder Yield: 9.33%; 1.05%
Dividend Per Share: $0.60; $0.72
Dividend Growth (YoY): 0.00%; 4.88%
Years of Dividend Growth: 0; 0
Payout Ratio: 31.1%; 24.3%
FCF Payout Ratio: 16.5%; 22.0%

Taxes and interestIndustry

Income Tax: $37.50M; $1.63M
Effective Tax Rate: 30.0%; 18.3%

Scores and fair valueIndustry

Altman Z-Score: 1.33; 2.44
Piotroski F-Score: 5; 5
Beneish M-Score: -3.11; -2.64

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	EMBC	S&P 500	Difference	EMBC per year	S&P 500 per year
1 month	+7.3%	-2.7%	+10.0 pts
3 months	+35.6%	-1.7%	+37.4 pts
Year to date	-44.8%	+11.9%	−56.7 pts
1 year	-54.2%	+12.0%	−66.2 pts
3 years	-51.3%	+78.2%	−129.4 pts	-21.3%	+21.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

6M EMBC shares were sold short on Oct 30, 2026, down 0.9% from the previous report, or 10.68% of the shares available to trade. At recent volumes it would take 6.8 days to buy them back. Over the last 20 sessions, 57.6% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	5,815,555	-0.9%	851,646	6.8
Oct 15, 2026	5,870,247	+0.8%	952,685	6.2
Sep 30, 2026	5,825,802	+5.0%	1,073,095	5.4
Sep 15, 2026	5,547,979	-11.4%	1,243,043	4.5
Aug 31, 2026	6,265,110	+15.1%	1,351,061	4.6
Aug 14, 2026	5,444,035	-18.5%	2,215,635	2.5
Jul 31, 2026	6,681,557	+10.9%	1,138,485	5.9
Jul 15, 2026	6,025,861	+3.1%	1,545,559	3.9
Jun 30, 2026	5,845,178	-16.0%	3,327,347	1.8
Jun 15, 2026	6,954,937	-6.1%	1,696,912	4.1
May 29, 2026	7,407,133	+3.8%	2,240,582	3.3
May 15, 2026	7,136,512	+18.0%	5,191,804	1.4